4
Changes in Ownership
RenovoRx, Inc. Filed Acc 0001493152-24-009409
Options or other derivatives
- Chief Clinical Officer acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gentry Leesa Chief Clinical Officer | 2024-03-06 | Grant or award · Options | +190,000 | 190,000 | D | ||
Loading xslF345X05/ownership.xml…